3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cardiotoxicity
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Adenocarcinoma Of Esophagus
1
Interventions
fludarabine phosphate
15
Cyclophosphamide
13
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Tacrolimus
10
Etoposide
10
Rituximab
8
Mycophenolic Acid
8
Methotrexate
6
Melphalan
6
Cyclosporine
6
Busulfan
6
Antilymphocyte Serum
6
Vorinostat
4
Sirolimus
4
Prednisone
4
Lenalidomide
4
Immunohistochemistry
4
Gene Expression Profiling
4
Carboplatin
4
Vincristine
3
Microarray Analysis
3
Gemcitabine
3
Everolimus
3
Doxorubicin
3
Dexamethasone
3
Brentuximab Vedotin
3
Alemtuzumab
3
10-propargyl-10-deazaaminopterin
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoblastic Lymphadenopathy
×
Mass Spectrometry
×
Clear all
No trials found.